Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms
12 January 2026
2 mins read

Klarna Group plc stock (KLAR) slides as Trump’s 10% credit-card cap talk jolts lenders, lawsuit deadline looms

New York, Jan 12, 2026, 10:18 (ET) — Regular session

  • Klarna shares dropped roughly 4.8%, slipping to $29.96 in early trading after wrapping up Friday at $31.45.
  • Trump’s plan to cap credit-card interest rates at 10% for one year is sending shockwaves through consumer finance stocks.
  • Investors are keeping an eye on the Feb. 20 deadline for lead plaintiffs in a securities class action linked to an IPO.

Klarna Group plc shares dropped 4.8% to $29.96 in early Monday trading, down from an opening price of $32.33, as investors digested new policy risks tied to U.S. consumer lending and increased legal scrutiny on the recently listed fintech. 1

The shift follows U.S. President Donald Trump’s proposal to cap credit-card interest rates at 10% for one year beginning Jan. 20. Wall Street experts warned that such a wide-ranging cap would almost certainly need Congress approval, with slim chances of making it through. Still, the announcement rattled stocks in lenders and payment companies. 2

A rate cap would slice into one of consumer banking’s most lucrative areas, reshaping who receives credit and under what conditions. Credit card rates currently average around 19.65%, with outstanding balances hitting $1.23 trillion by the end of Q3, according to Bankrate and Federal Reserve figures cited by Reuters. Imposing a cap might steer more borrowers toward alternatives like buy now, pay later plans — short-term installment loans offered at checkout. 3

U.S. financial stocks took a broad hit Monday, though some alternative lending firms fared better. Brian Jacobsen, chief economic strategist at Annex Wealth Management, noted, “When companies can’t price the risk properly, they’ll just reduce credit lines or cut off access to credit entirely. Buy now pay later firms and payday lenders might love this proposal.” Investors will be watching bank earnings reports this week closely for clues on how lenders intend to react. 4

Klarna CEO Sebastian Siemiatkowski threw his support behind the rate-cap proposal, saying the current setup favors wealthier consumers while others face high interest charges. “It’s not a fair system,” Siemiatkowski told The Times. 5

Litigation news has weighed heavily on the stock. Faruqi & Faruqi announced Sunday night that investors have until Feb. 20 to apply to be lead plaintiff in a federal securities class action linked to Klarna’s September 2025 IPO. The lawsuit claims the company and certain executives made misleading statements or left out risks around rising loss reserves. 6

Klarna, the Swedish payments company famous for its BNPL service, went public in New York last September, pricing its shares at $40 each. The stock surged on its first day, according to Reuters. But as of Monday, the shares have fallen sharply, trading well under the IPO price. 7

Credit quality continues to challenge investors. Klarna’s debut earnings as a public company in November revealed revenue growth that surpassed forecasts, yet higher credit loss provisions dragged the shares down, Reuters noted. 8

But the policy headline remains just that — a headline. Without congressional action, the cap might disappear, triggering a swift market reversal. Klarna’s bigger short-term threat is tighter bank credit, which could drive more weak borrowers to BNPL, boosting volumes but also sparking higher defaults and funding costs.

Stock Market Today

Astera Labs (ALAB) stock closes near $170 after 19% jump as earnings week looms

Astera Labs (ALAB) stock closes near $170 after 19% jump as earnings week looms

8 February 2026
New York, Feb 7, 2026, 20:34 (EST) — Market closed. Astera Labs, Inc. shares surged 18.9% on Friday to close at $169.85, after ending the prior session at $142.82. The stock traded between $151.42 and $170.01, with about 7.3 million shares changing hands. 1 With U.S. markets shut for the weekend, the move leaves the Nasdaq-listed chip-connectivity firm in focus heading into Monday’s open. Attention now shifts to its quarterly report due next week, a key check on demand for parts that sit inside AI data centers. Astera Labs makes connectivity chips and software that help move data inside servers
Sungrow Power Supply (300274.SZ) A-shares: Monday watch after “commercial space” denial

Sungrow Power Supply (300274.SZ) A-shares: Monday watch after “commercial space” denial

8 February 2026
Sungrow closed at 144.50 yuan, down 1.03%, after stating it has no plans in the commercial space sector. Mainland China trading resumes Monday, with Spring Festival closures set for Feb. 15–23. Major funds were net sellers of 5.46 billion yuan on Feb. 6. The Shenzhen-listed solar firm remains under scrutiny as investors await further filings before the holiday.
MPWR stock price hits a new high after Monolithic Power’s outlook — what traders watch next week

MPWR stock price hits a new high after Monolithic Power’s outlook — what traders watch next week

8 February 2026
Monolithic Power Systems shares surged 6.4% to $1,229.82 Friday, hitting a new 52-week high after raising its dividend to $2.00 and forecasting first-quarter revenue of $770 million to $790 million. CEO Michael Hsing filed a Rule 144 notice for 3,082 shares. CFO Bernie Blegen will retire after the 2025 annual report, with Rob Dean named interim CFO. Fourth-quarter revenue rose 20.8% to $751.2 million.
Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls

Microchip Technology stock price: MCHP heads into Monday after earnings outlook and mixed analyst calls

8 February 2026
Microchip Technology shares fell 2.6% to $76.01 Friday after its outlook and analyst reactions disappointed some investors. The company reported fiscal Q3 net sales up 15.6% to $1.186 billion and guided March-quarter sales to $1.24–$1.28 billion. A global memory shortage has disrupted orders, and analysts remain split on recovery prospects. BlackRock disclosed a 10% stake as of Jan. 31.
Teva stock jumps after $500 million Royalty Pharma deal as investors eye JPM update
Previous Story

Teva stock jumps after $500 million Royalty Pharma deal as investors eye JPM update

Duolingo stock sinks on CFO exit, new finance chief pay package and early Q4 user update
Next Story

Duolingo stock sinks on CFO exit, new finance chief pay package and early Q4 user update

Go toTop